In our study, we investigated the relationship between PD-1 and PD-L1 molecules and drug resistance in the context of chemotherapy- and immunotherapy-focused treatments, using an in vitro breast cancer model developed with monocyte and lymphocyte cells to explore the immune basis of breast cancer. This evidence concerns the gene PDCD1 and breast cancer.